ClinicalTrials.Veeva

Menu

One Brand-new Maneuver to Place Nasoenteric Tube

B

Buddhist Tzu Chi General Hospital

Status

Unknown

Conditions

Nutrient Intake Disorder

Treatments

Device: ultrathın esophagogastroduodenoscope

Study type

Interventional

Funder types

Other

Identifiers

NCT04222179
IRB106-10-A

Details and patient eligibility

About

Naso-enteric tube feeding is necessary for certain patients. Many methods are used to place a naso-enteric tube, such as bed-side blind method, fluoroscopy method and guide-wire method. INvestigators aim to introduce a safe, non-expensive and fast method to insert a silicon naso-gastric (NG) tube into the small intestine.

Full description

Investigators tied a 1-cm surgical suture at the tip of a 16 French silicon NG tube (120 cm long, cost 5 US dollars). One conventional EGD (diameter 2.8 mm) biopsy forceps was inserted into the lumen as a strengthened stylet. Then investigators inserted a biopsy forceps (diameter 2.0 mm) and protruded a little out of the working channel of an ultrathin EGD scope (Fujinon EG 530 N, diameter 5.9 mm) to grasp the suture. The ultrathin EGD and NG tube were parallelly pushed into a selected nostril after adequate decongestive anesthesia (Epinephrine 0.3% + Lidocaine 5%) into the small intestine as deep as possible to the jejunum.

Being placed to the small intestine as far as possible, the NG tube was released and the ultrathin EGD scope withdrew. When the scope was pulled backwards from the stomach, the shape/layout of a NG-tube could be simultaneously monitored and adjusted. At last, the EGD biopsy forceps (2.8 mm) inside the NG tube was removed. With this method, in real life, a plain film is not necessary to confirm the NG tube position. However, for study purpose, a KUB film was taken to check the NG tube position.

Enrollment

100 estimated patients

Sex

All

Ages

20 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Esophageal obstruction
  2. Gastric outlet obstruction
  3. Duodenal obstruction
  4. Pancreatitis
  5. Gastroparesis -

Exclusion criteria

  • (1)Coagulopathy (2)Deviation of nasal septa (3)Conscious disturbance

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Naso-enteric tube placement
Other group
Description:
The participants needed nutrition from naso-enteric tube feeding are enrolled into this study. Double-blind was not needed here.
Treatment:
Device: ultrathın esophagogastroduodenoscope

Trial contacts and locations

1

Loading...

Central trial contact

Jen S Lin, VS; Chi T Hu, VS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems